RS03. A Matched Cohort Comparison of Outcomes in Patients Who Underwent Fenestrated Endovascular Aortic Aneurysm Repair Using Physician-Modified Endovascular Grafts vs Company-Manufactured Devices
Fenestrated endografts are customized, patient-specific, endovascular devices with the potential to reduce morbidity and mortality of repair of complex aortic aneurysms. With approval from the United States Food and Drug Administration, our center began performing fenestrated endovascular aneurysm repair through a physician-sponsored investigational device exemption (IDE #G130210), using both physician-modified endografts (PMEG) and company manufactured devices (CMD). Because PMEG and CMD are each associated with specific advantages and disadvantages, we sought to investigate differences in outcomes between PMEG and CMD cases.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Shernaz Dossabhoy, Andres Schanzer, Jessica Simons, Julie Flahive, Francesco Aiello, Parth Sheth, Edward Arous, Louis Messina Tags: S1: William J. von Liebig Forum Source Type: research